Clinical Trials · NCT00171613
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novartis
- Enrollment
- 32
- Start date
- Feb 2005
- Locations
- See registry
- Primary endpoint
- Change from baseline in BMI